Dr. Lal PathLabs Limited is one of Bharat’s leading consumer healthcare brand in diagnostic services. The share price is currently 42% down from its lifetime high. It is constantly earning profit and has reduced its debt in the past few years. the company is also maintaining a healthy dividend yield. Promoter has not pledged their shares. So it is a good buy currently as the whole market is at a premium valuation and such gems are hard to find which are 42% down from lifetime high. Good for Investment purpose.
Note- Do your own analysis before investing
Note- Do your own analysis before investing
